Human CRACC/SLAMF7 Antibody, R&D Systems™

Mouse Monoclonal Antibody has been used in 1 publication

Catalog Number	Mfr. No.	Quantity
MAB1906SP	R&D Systems MAB1906SP	25 μg
MAB1906100	R&D Systems MAB1906100	100 μg
MAB1906500	R&D Systems MAB1906500	500 μg

Description

CRACC/SLAMF7 Monoclonal specifically detects CRACC/SLAMF7 in Human samples. It is validated for Flow Cytometry, CyTOF-ready.

Specifications

• Antigen: CRACC/SLAMF7
• Concentration: LYOPH
• Applications: Flow Cytometry, CyTOF
• Conjugate: Unconjugated
• Regulatory Status: RUO
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
• Gene Alias: 19A, CD2 subset 1, CD2-like receptor activating cytotoxic cells, CD319, CD319 antigen, CRACCCD2-like receptor-activating cytotoxic cells, CS119A24 protein, Membrane protein FOAP-12, Novel Ly9, novel LY9 (lymphocyte antigen 9) like protein, Protein 19A, SLAM family member 7, SLAMF7
• Gene Symbols: SLAMF7
• Isotype: IgG2a
• Purification Method: Protein A or G purified from hybridoma culture supernatant
• Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

• Clone: 235614
• Dilution: Flow Cytometry 2.5 ug/10^6 cells, CyTOF-ready
• Classification: Monoclonal
• Host Species: Mouse
• Target Species: Human
• Gene Accession No.: Q9NQ25
• Gene ID (Entrez): 57823
• Immunogen: Mouse myeloma cell line NS0-derived recombinant human CRACC/SLAMF7 Lys27-Ser225 Accession # Q9NQ25
• Primary or Secondary: Primary
• Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
• Test Specificity: Detects human CRACC/SLAMF7 in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant human NTB-AR is observed.

For Research Use Only